Clinical trial
High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple…
NCT00186238 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186238 |
|---|---|
| Title | High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma |
| Official title | High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Procedure |
| Interventions | high dose chemotherapy then autologous hematopoietic cell transplant |
| Enrollment | 300 |
| Start date | Sep 1, 1994 |
| Primary completion | Sep 1, 2006 |
| Completion | Apr 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 14, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: